HomeCompareNUVA vs GBDC

NUVA vs GBDC: Dividend Comparison 2026

NUVA yields 5.03% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.75M in total portfolio value
10 years
NUVA
NUVA
● Live price
5.03%
Share price
$39.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.8K
Annual income
$694.15
Full NUVA calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — NUVA vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNUVAGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NUVA + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NUVA pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUVA
Annual income on $10K today (after 15% tax)
$427.67/yr
After 10yr DRIP, annual income (after tax)
$590.03/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $13,930,283.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUVA + GBDC for your $10,000?

NUVA: 50%GBDC: 50%
100% GBDC50/50100% NUVA
Portfolio after 10yr
$10.40M
Annual income
$8,194,978.78/yr
Blended yield
78.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NUVA right now

NUVA
Analyst Ratings
13
Buy
21
Hold
1
Sell
Consensus: Hold
Price Target
$58.00
+45.9% upside vs current
Range: $50.00 — $64.00
Altman Z
1.9
Piotroski
7/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUVA buys
1
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Lois Frankel🏢 House$NUVA▼ Sell$1,001 - $15,0002022-02-14
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
Lois Frankel🏢 House$NUVA▲ Buy$1,001 - $15,0002018-05-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNUVAGBDC
Forward yield5.03%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$27.8K$20.78M
Annual income after 10y$694.15$16,389,263.41
Total dividends collected$6.0K$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy
Analyst price target$58.00$14.00

Year-by-year: NUVA vs GBDC ($10,000, DRIP)

YearNUVA PortfolioNUVA Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$11,203$503.14$12,490$1,790.28$1.3KGBDC
2$12,514$526.80$16,522$3,157.73$4.0KGBDC
3$13,940$549.96$23,578$5,898.68$9.6KGBDC
4$15,488$572.54$37,115$11,886.75$21.6KGBDC
5$17,167$594.52$66,136$26,423.57$49.0KGBDC
6$18,985$615.85$137,257$66,491.44$118.3KGBDC
7$20,950$636.49$341,734$194,868.54$320.8KGBDC
8$23,073$656.44$1,050,788$685,133.02$1.03MGBDC
9$25,364$675.66$4,099,314$2,974,971.01$4.07MGBDC
10$27,834$694.15$20,775,530$16,389,263.41$20.75MGBDC

NUVA vs GBDC: Complete Analysis 2026

NUVAStock

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Full NUVA Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this NUVA vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUVA vs SCHDNUVA vs JEPINUVA vs ONUVA vs KONUVA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.